MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2026.116613

Медицинская библиотека · International immunopharmacology · 2026

Anacardic acid mitigates traumatic brain injury-induced inflammatory damage: involvement of TLR4/MyD88/NF-κB pathway regulation and inhibition of P300 HAT activity on NF-κB acetylation.

Yang Chenguang, Ru Junnan, Zhang Xingxing, Kong Xiaobin, Zhu Chaoran, Gao Zhuqi, Chen Fatao, Zheng Kaiwei, Jin Kunlin, Zhuge Qichuan, Yang Su, Huang Lijie

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Traumatic brain injury (TBI) triggers neuroinflammation and NLRP3 inflammasome-dependent pyroptosis, causing substantial neuronal damage. Anacardic acid (AA), a natural histone acetyltransferase (HAT) inhibitor, has anti-inflammatory properties related to TBI. This study explored AA's effects on pyroptosis and its neuroprotective potential after TBI.

METHODS

A controlled cortical impact (CCI) mouse model was employed. Neurological recovery was evaluated by mNSS and rotarod tests, lesion volume by H&E staining, and neuronal survival by NeuN/TUNEL immunofluorescence. Inflammatory cytokines were measured via ELISA, and inflammatory-related proteins by western blotting. Pyroptosis was assessed through LDH release, GSDMD cleavage, and microglial IBA-1/cleaved Caspase-1 (p20) immunostaining. The role of P300 in NF-κB acetylation was determined using CTB (an activator of HAT) and P300 knockdown via siRNA.

RESULTS

AA treatment reduced brain lesion volume, improved neurological function, and promoted cortical neuronal survival. It significantly decreased pro-inflammatory cytokine levels (IL-1β, IL-6, IL-18, TNF-α), inhibited NLRP3 inflammasome assembly, and blocked microglial pyroptosis. AA also suppressed the TLR4/MyD88/NF-κB pathway and upstream NF-κB activation. Remarkably, p300 knockdown exacerbated NF-κB acetylation and NLRP3 inflammasome assembly, while CTB administration reversed these effects.

CONCLUSIONS

AA confers neuroprotection in TBI by alleviating neuroinflammation and NLRP3-dependent pyroptosis. This is achieved by inhibiting the TLR4/MyD88/NF-κB pathway and suppressing p300-mediated NF-κB acetylation, suggesting AA's therapeutic potential for TBI.

Для цитирования: Yang Chenguang, Ru Junnan, Zhang Xingxing, Kong Xiaobin, Zhu Chaoran, Gao Zhuqi, Chen Fatao, Zheng Kaiwei, Jin Kunlin, Zhuge Qichuan, Yang Su, Huang Lijie. Anacardic acid mitigates traumatic brain injury-induced inflammatory damage: involvement of TLR4/MyD88/NF-κB pathway regulation and inhibition of P300 HAT activity on NF-κB acetylation.. International immunopharmacology. 2026. DOI: 10.1016/j.intimp.2026.116613.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.